Point-of-care devices are used for early detection and management of disease of the patients. Technologies such as biosensors, assays, lab-on-chip and many others are aiding towards the development of these point of care devices. The major driver contributing to the growth of the point-of-care diagnostics market is the increasing prevalence of chronic and infectious diseases across the globe. In addition, the market growth is also attributed to increasing demand for technologically advanced point-of-care devices, and new government initiatives. However, factors such as the high cost of such devices and lack of skilled staffs may hamper the growth of the market.
The global point-of-care diagnostics market can be segmented on the basis of application, prescription mode, and end user. On the basis of the application, it can be further classified into cardiology, diabetes, infectious diseases, oncology and other applications. Among these, the diabetes segment has significant share attributed to the increase in numbers of people suffering from diabetes across the globe. According to the International Diabetes Federation (IDF), diabetes has affected approximately 425 million adults globally in 2017-2018 and it is expected to increase to 629 million by 2045. On the basis of the end-user, the market is classified into hospital and clinics, home care, and other. Among these, the hospitals and clinics are expected to show the highest growth attributed to increasing government initiatives.
The global point-of-care diagnostics market is further analyzed and segmented on the basis of regions into North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to have significant market share in the global point-of-care diagnostics market. This is mainly attributed to the high prevalence of diseases, development of healthcare infrastructure and mostly due to the presence of major players such as Abbott Laboratories, Inc. and Danaher Corp. Asia-Pacific is considered to witness the significant growth in the global point-of-care diagnostics market during the forecast period. The increasing quality of the healthcare system and increasing awareness among people in emerging countries, such as India, are the reason for the high market growth.
Major market players operating in the global point-of-care diagnostics market include F. Hoffmann-La Roche Ltd., Danaher Corp., Abbott Laboratories, Inc., bioMérieux SA, and Siemens Healthcare GmbH among others. These companies adopt various strategies such as partnership & collaborations, finding a new market or Product innovations in their core competency in order to stay competitive in the market. For instance, In October 2017, Abbott Laboratories acquired Alere Inc. to strengthen the point-of-care device segment of the company.
Research Methodology
The market study of the global point-of-care diagnostics market is incorporated by extensive primary and secondary research conducted by a research team. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behaviour and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary Sources Include
The report is intended for healthcare companies, research organizations, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview and Insights
2.1. Scope of the Study
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Abbott Laboratories, Inc.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. F. Hoffmann-La Roche, Ltd.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Danaher Corp.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. EKF Diagnostics Holdings PLC
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Siemens Healthcare GmbH
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Point-of-care Diagnostic Market by Application
5.1.1 Cardiology
5.1.2 Diabetes
5.1.4 Infectious Diseases
5.1.4 Oncology
5.1.5 Other Applications (Haematology Testing, Pregnancy Testing)
5.2. Global Point-of-care Diagnostic Market by Prescription Mode
5.2.1. Over-The-Counter Testing
5.2.2. Prescription-Based Diagnostics
5.3. Global Point-of-care Diagnostic Market by End-User
5.3.1. Hospitals and Clinics
5.3.2. Home Care
5.3.3. Other (Ambulatory Care)
6. Regional Analysis
6.1. North America
6.1.1. The US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. AccuBioTech Co., Ltd.
7.3. Becton, Dickinson, and Co.
7.4. Biomeme, Inc.
7.5. bioMerieux SA
7.6. Bio-Rad Laboratories, Inc.
7.7. Chembio Diagnostics Systems, Inc.
7.8. Danaher Corp.
7.9. DNAe Group Holdings, Ltd.
7.10. EKF Diagnostics Holdings PLC
7.11. F. Hoffmann-La Roche, Ltd.
7.12. Instrumentation Laboratory SpA
7.13. Nova Biomedical Corp.
7.14. Qiagen N.V.
7.15. Quidel Corp.
7.16. Sekisui Diagnostics LLC
7.17. Siemens Healthcare GmbH
7.18. Sinocare, Inc.
7.19. Sysmex Corp.
7.20. Trinity Biotech PLC
LIST OF TABLES
1. GLOBAL POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025($ MILLION)
2. GLOBAL CARDIOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
3. GLOBAL DIABETES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
4. GLOBAL INFECTIOUS DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
5. GLOBAL ONCOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
6. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
7. GLOBAL POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY PRESCRIPTION MODE, 2018-2025($ MILLION)
8. GLOBAL OVER-THE-COUNTER TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
9. GLOBAL PRESCRIPTION-BASED DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
10. GLOBAL POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY END USER, 2018-2025($ MILLION)
11. GLOBAL HOSPITAL AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
12. GLOBAL HOMECARE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
13. GLOBAL LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
14. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025($ MILLION)
15. GLOBAL POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025($ MILLION)
16. NORTH AMERICAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025($ MILLION)
17. NORTH AMERICAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025($ MILLION)
18. NORTH AMERICAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY PRESCRIPTION MODE, 2018-2025($ MILLION)
19. NORTH AMERICAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY END USER, 2018-2025($ MILLION)
20. EUROPEAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025($ MILLION)
21. EUROPEAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025($ MILLION)
22. EUROPEAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY PRESCRIPTION MODE, 2018-2025($ MILLION)
23. EUROPEAN POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY END USER, 2018-2025($ MILLION)
24. ASIA-PACIFIC POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025($ MILLION)
25. ASIA-PACIFIC POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025($ MILLION)
26. ASIA-PACIFIC POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY PRESCRIPTION MODE 2018-2025($ MILLION)
27. ASIA-PACIFIC POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY END USER, 2018-2025($ MILLION)
28. REST OF THE WORLD POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025($ MILLION)
29. REST OF THE WORLD POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY PRESCRIPTION MODE, 2018-2025($ MILLION)
30. REST OF THE WORLD POINT-OF-CARE DIAGNOSTIC MARKET RESEARCH AND ANALYSIS BY END USER, 2018-2025($ MILLION)